Log In
person
Morphosys AG, Martinsried
MOR
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (EUR) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (EUR) | Percentage |
| Biotechnology |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
116.39M | 48.84% |
| Biotechnology |
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
|
85.04M | 35.69% |
| Biotechnology |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
36.86M | 15.47% |
| keyboard_arrow_down |
Biotechnology
Pharmaceutical Patent Licensing
|
116.39M | 48.84% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Biotechnology
Branded Pharmaceuticals (outsourced)
|
85.04M | 35.69% |
| keyboard_arrow_right |
These companies research, develop, and outsource the manufacturing of patented drugs.
|
||
| keyboard_arrow_down |
Biotechnology
Pre-Revenue Pharmaceuticals
|
36.86M | 15.47% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||